BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Inflammatory disorder
,
Retina
,
Nosology
,
Valproic acid
,
rs4950928
,
CXCL2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
sl 1
Summary
General Info
Curated Studies
Most Correlated Studies
Embryonic fibroblasts in response to infection with different strains of Toxoplasma gondii
Effect of MSL1, MSL3 and MOF RNAi knock downs in Drosophila SL-2 and Kc cells
Sodium lauryl sulfate (SLS) and nonanoic acid (NON) exposure-induced gene expression in human skin
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Establishment of matrix metalloproteinase 3 time-resolved immunoassay and some potential clinical ap…
The promoter methylations of the autoimmune regulator (AIRE) gene and matrix metalloproteinase-3 (MM…
Concentration of Serum Matrix Metalloproteinase-3 in Patients With Primary Biliary Cholangitis.
Increasing of matrix metalloproteinase 3 in bovine endometritis.
A computational study to assess the polymorphic landscape of matrix metalloproteinase 3 promoter and…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adult…
Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML
RESET Trial - Part 1 (Followed by Reset Trial - Part 2) - A Phase 3 Trial in Subjects With Sjögren-L…
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ